Table Of ContentCOMPETITIVE STRATEGIES ADOPTED BY PHARMACEUTICAL FIRMS IN 
KENYA 
 
 
 
 
 
BY 
ODHIAMBO AGNES ADHIAMBO 
 
 
 
 
 
 
A RESEARCH PROJECT SUBMITTED IN PARTIAL FULFILMENT OF THE 
REQUIREMENT FOR THE AWARD OF THE DEGREE OF MASTER OF 
BUSINESS ADMINISTRATION, SCHOOL OF BUSINESS, UNIVERSITY OF 
NAIROBI. 
 
 
NOVEMBER, 2013
DECLARATION 
This research project is my original work and has not been submitted for a degree course 
in this, or any other university. 
 
Signature……………………………                    Date……………………………………. 
ODHIAMBO AGNES ADHIAMBO 
D61/71410/2008 
 
 
 
 
This  research  project  has  been  submitted  for  examination  with  my  approval  as  the 
university supervisor. 
 
Signature………………………..                         Date…………………………………….. 
DR. REGINA KITIABI 
Department of Business Administration, School of Business 
University of Nairobi 
 
ii
DEDICATION 
To  my  family  and  in  particular  my  husband  Basil  Odhiambo  for  the  support  and 
encouragement, to my children Cindy and Arkipo for giving me the reason to study and 
work hard. 
iii
ACKNOWLEDGEMENT 
The successful completion of this MBA program has been as a result of the support from 
God, His grace was sufficient all through, Glory and Honor to him. 
Special  thanks  to  my  supervisor  Dr.  Regina  Kitiabi  for  her  advice,  guidance  and 
suggestions throughout the project.  
To  my  family,  especially  to  my  Spouse  Basil  Odhiambo  for  constant  support  and 
encouragement throughout my MBA programme,  
Appreciation to my classmates for their support in one way or another toward successful 
completion of this project and the entire MBA project. 
MAY THE ALMIGHTY GOD BLESS YOU ALL! 
iv
ABSTRACT 
The primary purpose of the study was to study competitive entry strategies adopted by 
pharmaceutical  companies  in  Kenya.  The  target  population  was  managers,  head  of 
departments and top management of pharmaceutical companies in Kenya. The results of 
the study were both qualitative and quantitative. Quantitative data collected using a 
questionnaire were also analyzed by the use of descriptive statistics using the Statistical 
Package for Social Sciences (SPSS) and presented through percentages, means, standard 
deviations and frequencies. The information was also represented by use of bar charts, 
graphs  and  pie  charts  and  in  prose-form.  This  was  done  by  tallying  up  responses, 
computing percentages of variations in response as well as describing and interpreting the 
data in line with the study objectives through use of SPSS. In assessing competitive 
forces and the context within which a company operates, choice of strategy can indeed 
seem like a search for a myriad forces pushing and pulling an organization to change and 
little by way of established principles to determine what the choice should be. However, 
the choice of strategy is fundamental to a company for a number of reasons. The study 
recommends  further  research  on  governments  need  to  develop  effective  marketing 
systems in the pharmaceutical sector by providing political and social economic changes 
in the efforts to give priority for the sector to be effective. There is need for initiatives to 
be taken for us to create a sustained and stable competitive strategy and for regional 
demand to be able to adjust to foreign technologies needed in the industry. From the 
study  there  is  need  for  competitive  advantage  as  an  entry  strategy  for  competitive 
strategies on pharmaceutical industry. 
 
v
TABLE OF CONTENTS 
DECLARATION ................................................................................................................ ii 
DEDICATION ................................................................................................................... iii 
ACKNOWLEDGEMENT ................................................................................................. iv 
ABSTRACT ........................................................................................................................ v 
LIST OF TABLES ............................................................................................................. ix 
LIST OF FIGURES ............................................................................................................ x 
CHAPTER ONE: INTRODUCTION ............................................................................. 1 
1.1 Background of the study ................................................................................................. 1 
1.1.1 The concept of competitive entry strategy ............................................................... 2 
1.1.2 Organizational performance .................................................................................... 5 
1.1.3 Pharmaceutical industry in Kenya ........................................................................... 5 
1.1.4 Foreign pharmaceutical firms in Kenya ................................................................... 7 
1.2 Research Problem ........................................................................................................... 8 
1.3 Research objectives ....................................................................................................... 10 
1.4 Value of the study ......................................................................................................... 10 
CHAPTER TWO: LITERATURE REVIEW .............................................................. 12 
2.1 Introduction ................................................................................................................... 12 
2.2 Theoretical foundations of strategy:.............................................................................. 12 
Game theory and Strategic conflicts in strategic choice. .................................................... 12 
2.3 Competitive Strategies .................................................................................................. 14 
2.3.1 Differentiation Strategy ......................................................................................... 15 
2.3.2 Pricing strategy ...................................................................................................... 17 
2.3.3 Cost Leadership Strategy ....................................................................................... 19 
vi
2.3.4 Promotion Strategies .............................................................................................. 21 
2.4 Competitive Advantage ................................................................................................. 24 
CHAPTER THREE: RESEARCH METHODOLOGY ............................................. 26 
3.1 Introduction ................................................................................................................... 26 
3.2 Research Design ............................................................................................................ 26 
3.3 Study Population ........................................................................................................... 27 
3.4 Data collection .............................................................................................................. 27 
3.5 Data Analysis ................................................................................................................ 28 
3.6 Reliability and Validity ............................................................................................. 28 
CHAPTER FOUR: DATA ANALYSIS AND INTERPRETATION ......................... 30 
4.1 Introduction ................................................................................................................... 30 
4.2 Demographic Characteristics ........................................................................................ 30 
4.2.1 Gender ................................................................................................................... 31 
4.2.2 Respondents’ age category .................................................................................... 32 
4.2.3 Academic background ........................................................................................... 33 
4.2.4 Working experience ............................................................................................... 33 
4.2.5 How long have the company been in the competition ........................................... 35 
4.4 Competitive advantage .................................................................................................. 36 
4.5 Application of Differentiation Strategies as a Competitive entry Strategy ................... 37 
4.6 Rate in level of application of differentiation strategies ............................................... 38 
4.7 Innovation Differentiation Strategies ............................................................................ 38 
4.8 Extent at which company ensures success of its differentiation strategies ................... 40 
4.9 Pricing strategy ............................................................................................................. 41 
4.10 The extent at which the company uses pricing strategy as an entry strategy in the 
market ........................................................................................................................................ 41 
vii
4.11 Extent to which pricing strategy as an entry strategy in the market influences 
competitiveness of companies ................................................................................................... 42 
4.12 Cost Leadership strategy ............................................................................................. 44 
4.13 Promotion strategy ...................................................................................................... 45 
4.14 Extent at which company use promotion strategy as an entry strategy ....................... 46 
4.15 Promotional Strategies ................................................................................................ 47 
4.16 Promotion strategy as an entry strategy influences competitiveness of companies .... 48 
4.17 Findings in relation to literature review ...................................................................... 50 
CHAPTER FIVE: SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 54 
5.1 Introduction ................................................................................................................... 54 
5.2 Summary of findings ..................................................................................................... 54 
5.3 Discussion ..................................................................................................................... 55 
5.4 Conclusion .................................................................................................................... 57 
5.5 Limitations of the study ................................................................................................ 58 
5.6 Recommendations for policy, practice and further studies ........................................... 58 
REFERENCES ................................................................................................................ 60 
APPENDIX I: QUESTIONNAIRE .................................................................................. 64 
APPENDIX II: PHARMACEUTICAL COMPANIES (EU) ........................................... 70 
APPENDIX III: KNOWLEDGE GAP ............................................................................. 72 
viii
LIST OF TABLES 
Table 3.1: Study Population .............................................................................................. 27 
Table 4.2: Competitive advantage .................................................................................... 36 
Table 4.3: Rating the level of application of differentiation strategies ............................. 38 
Table 4.4: Level of innovation differentiation strategies .................................................. 39 
Table 4.5: Extent at which company ensures success of its differentiation strategies ..... 40 
Table 4.8: Extent to which pricing strategy as an entry strategy in the market influences 
competitiveness of companies .......................................................................................... 43 
Table 4.9: Cost Leadership strategy .................................................................................. 44 
Table 4.12:Promotional Strategies .................................................................................... 47 
Table 4.13: Promotion strategy as an entry strategy influences competitiveness of 
companies ......................................................................................................................... 49 
 
ix
LIST OF FIGURES
Figure 4.1 Gender ............................................................................................................. 31 
Figure 4.2: Age category................................................................................................... 32 
Figure 4.3: Academic background .................................................................................... 33 
Figure 4.4: Working experience ....................................................................................... 34 
Figure 4.5: How long have the companies been in the competition ................................. 35 
Figure 4.6: Differentiation Strategies ............................................................................... 37 
Figure 4.7: Pricing strategy ............................................................................................... 41 
Figure4.8: Extent at which the company uses pricing strategy as an entry strategy in the 
market ............................................................................................................................... 42 
Figure 4.9: Promotion strategy ......................................................................................... 45 
Figure 4.10: Promotion strategy ....................................................................................... 46 
 
 
 
 
 
 
 
 
x
Description:departments and top management of pharmaceutical companies in Kenya. The results of the study  study there is need for competitive advantage as an entry strategy for competitive strategies on  forces in the market and the context within which the company considers itself in the market (Johnson